Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership19,030 shares
Latest Disclosed Value $ 767,100
Pnc Financial Services Group, Inc. reports 8.28% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 19,030 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $656,345 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 17,575 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 8.28% during the quarter. The current value of the position is $1,203,457 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 19,030 1,455 8.28 767 25.53 0.0004
2026-02-06 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 17,575 2,775 18.75 612 -50.33 0.0003
2025-11-07 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 14,800 1,529 11.52 1,230 26.28 0.0007
2025-08-08 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,271 81 0.61 974 -35.33 0.0006
2025-05-09 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,190 2,584 24.36 1,507 182.02 0.0008
2025-02-07 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 10,606 -54 -0.51 534 8.32 0.0004
2024-11-08 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 10,660 -209 -1.92 493 39.66 0.0003
2024-08-09 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 10,869 62 0.57 353 29.78 0.0002
2024-05-10 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 10,807 -201 -1.83 272 -23.81 0.0002
2024-03-22 2023-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 11,008 2,432 28.36 358 53.22 0.0003
2024-02-09 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 11,008 2,432 358 0.0001
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 8,576 -157 -1.80 234 20.10 0.0002
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 8,733 1,025 13.30 194 16.87 0.0002
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 7,708 -1,465 -15.97 167 -10.75 0.0001
2023-02-10 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 9,173 231 2.58 186 -18.42 0.0002
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 8,942 1,837 25.86 228 35.71 0.0002
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 7,105 298 4.38 168 9.09 0.0002
2022-05-12 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 6,807 406 6.34 154 22.22 0.0001
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 6,401 -635 -9.03 126 -9.35 0.0001
2021-11-05 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 7,036 992 16.41 139 4.51 0.0001
2021-08-06 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 6,044 -540 -8.20 133 -15.82 0.0001
2021-05-07 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 6,584 89 1.37 158 -7.06 0.0002
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 6,495 402 6.60 170 61.90 0.0002
2020-11-06 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 6,093 -222 -3.52 105 0.00 0.0001
2020-08-28 2020-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 6,315 419 7.11 105 50.00 0.0001
2020-08-07 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 6,315 419 105 21.8020
2020-05-08 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 5,896 -2,938 -33.26 70 -33.96 0.0001
2020-02-07 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 8,834 -116,717 -92.96 106 -94.02 0.0001
2019-11-08 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 125,551 -36,883 -22.71 1,773 -2.04 0.0018
2019-08-09 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 162,434 -48,087 -22.84 1,810 -26.72 0.0018
2019-05-10 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 210,521 -253,791 -54.66 2,470 -60.18 0.0025
2019-02-08 2018-12-31 13F CORCEPT TH Common Stock 218352102 464,312 456,876 6,144.11 6,203 5,864.42 0.0069
2018-11-09 2018-09-30 13F CORCEPT TH Common Stock 218352102 7,436 -67,594 -90.09 104 -91.18 0.0001
2018-08-10 2018-06-30 13F CORCEPT TH Common Stock 218352102 75,030 3,016 4.19 1,179 -0.51 0.0012
2018-05-11 2018-03-31 13F CORCEPT TH Common Stock 218352102 72,014 -213,351 -74.76 1,185 -77.00 0.0012
2018-02-09 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 285,365 -19,814 -6.49 5,152 -12.54 0.0050
2017-11-13 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 305,179 295,342 3,002.36 5,891 4,978.45 0.0061
2017-08-11 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 9,837 3,390 52.58 116 61.11 0.0001
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 6,447 6,447 72 0.0001
2016-11-04 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -429 -100.00 0 -100.00
2016-08-05 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 429 -16 -3.60 2 0.00 0.0000
2016-05-06 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 445 15 3.49 2 0.00 0.0000
2016-02-05 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 430 0 0.00 2 0.00 0.0000
2015-11-06 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 430 14 3.37 2 -33.33 0.0000
2015-08-05 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 416 121 41.02 3 50.00 0.0000
2015-05-08 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 295 295 2 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.